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Abstract
Background: The present study aimed to characterize Mycobacterium tuberculosis population structure and to
identify transmission chains and risk factors by prospective molecular typing in conjunction with conventional
epidemiological investigations in the French overseas department of Guadeloupe.
Methods: The study included all the culture-positive TB cases (1 clinical isolate per patient; n = 129) diagnosed
between a seven year period (April 4th, 1999 to December 31st, 2005). Prospective molecular typing was performed
using spoligotyping and VNTRs, and a subset of 44M. tuberculosis isolates found to be clustered was retrospectively
typed using 12-loci MIRUs. Data were compared using the SITVIT2 database, followed by analysis of risk factors in
function of clustering of the isolates and available demographic and socioeconomic data.
Results: The study sample was characterized by a majority of new cases (87.4%); a moderate proportion of drug-
resistance (7.8%); a high level of immigration (51.2% foreign-born) originating from high TB/HIV incidence
neighboring islands such as Haiti or Dominican Republic; lower socioeconomic conditions (70.7% of jobless,
average income 824 EUR/month); and a significantly higher proportion of TB/HIV co-infected cases (38.2% vs. 8.5%;
p < 0.001), and extrapulmonary disease (18.2% vs. 4.8%; p < 0.02) among migrants as compared to French patients.
The study revealed an important delay in access to healthcare with a median delay of 74.5 days between the 1st
symptoms and clinical suspicion of TB. Prospective molecular typing based on spoligotyping and 5-loci VNTRs
showed that evolutionary recent Euro-American lineages predominated in Guadeloupe (91.5% of isolates). In
conjunction with epidemiological data, it allowed to estimate a recent transmission rate of 18.6%, which was close
to the rate of 16.7% estimated using retrospective 12-loci MIRU typing. Although a higher proportion of cases in
older age-group were apparently linked to reactivation; univariate analysis of risk factors did not allow pinpointing
specific risk factors for a patient to belong to a TB transmission group.
Conclusions: Ongoing TB transmission in the insular, low TB-incidence setting of Guadeloupe can be defined as
follows: (i) a significant proportion of imported cases of the disease from neighboring islands; (ii) significantly higher
TB/HIV coinfection among foreign-born cases; and, (iii) a higher proportion of cases affecting older age-group
among French patients due to reactivation. This study emphasizes the need for universal typing using
spoligotyping and 15-loci MIRUs in prospective studies.
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Background
There has been major progress in reducing tuberculosis
(TB) cases in the past two decades, yet the global bur-
den of TB remains enormous. The World Health
Organization (WHO) estimated that there were 8.7 mil-
lion incident cases of TB and 1.4 million deaths in 2011
[1]; HIV pandemic apparently played a major role in it,
since 13% of the TB patients were co-infected with HIV
and accounted for 30.7% of all deaths due to TB. Even if
most of the TB cases occurred in Asia (59%) and Africa
(26%), a non negligible proportion was reported in the
Eastern Mediterranean (7%) and European (5%) regions,
followed by the Americas (3%). To achieve the current
goal of a high level of case detection (75%) and cure
(85%) by the year 2015, a finer study of the epidemio-
logical characteristics of TB patients to pinpoint risk fac-
tors involved and access to health care is needed in
different regions of the world [2]. Molecular fingerprint-
ing of Mycobacterium tuberculosis has been proposed as
an ideal investigational strategy to achieve this objective,
since it allows to incorporate genotyping based cluster-
ing to quantify recent TB transmission in order to
analyze risk factors and access to health care [3-5]. We
hereby report results of such an investigational approach
under a prospective genotyping study covering TB trans-
mission during a 7 year period (1999–2005) in
Guadeloupe, a French overseas department of the
Americas. Under this study, all the M. tuberculosis
strains were characterized by spoligotyping [6] and Vari-
able Number of Tandem DNA Repeats (VNTRs; [7])
that were methods of choice when this investigation was
planned back in 1998, with the aim of determining po-
tential transmission links between TB patients. This
prospective study also undertook concomitant investiga-
tions to study the access to health care and follow-up of
the TB patients diagnosed.
Methods
Study design, patients, and M. tuberculosis isolates
After a prior explanation of the recommended investiga-
tions for the diagnostic purposes by a physician, patients
were asked to sign an agreement letter and the patho-
logical specimens were obtained from suspected tubercu-
losis patients. Only patients residing in Guadeloupe for
more than three months were eligible. The cultures were
performed using Löwenstein-Jensen slants at 37°C, and
were duly identified as M. tuberculosis complex using clas-
sical biochemical tests and the AccuProbe test (GenProbe
Inc., San Diego, CA). All positive cultures were also
subjected to drug-susceptibility testing using the pro-
portional method on Löwenstein-Jensen media. The study
performed between April 4th, 1999 and December 31st,
2005 corresponded to a recruitment of 129 TB pa-
tients with one M. tuberculosis clinical isolate per
patient. For each patient, the data requested included
nature of pathological specimen, result of AFB smear,
the date of diagnosis, the clinical form of the disease,
results of HIV serology, and previous history of TB.
Demographic and socioeconomic data as well as in-
formation relating to the diagnosis were collected by
the investigator after individually interviewing each
patient using a specific form.
Ethical considerations
The study protocol was presented to the Conseil
National de l’Ordre des Médecins (http://www.conseil-
national.medecin.fr/qu-est-ce-que-l-ordre-1206), which
guarantees the quality of healthcare provided to the pa-
tients. As recommended, it was thereafter submitted to
the Commission nationale de l’informatique et des
libertés (CNIL; http://www.cnil.fr/english/the-cnil/oper-
ation/#c1556) which ensures the protection of personal
data. Patients were duly informed about the description
and aims of the study in writing, and those enrolled after
their oral consent were asked to sign an agreement let-
ter, returned to investigators. The study was approved by
CNIL under a formal agreement number 999343 (mo-
dalities of registration, storage and analysis of epidemio-




Right from the beginning of the prospective study in
1999, the molecular typing was planned using two PCR-
based systems - spoligotyping [6] and VNTRs [7], since
this typing scheme is significantly cheaper and faster
than the historical “gold standard” IS6110-RFLP that
was used for earlier M. tuberculosis genotyping work in
Guadeloupe [8-10]; yet provided with results that were
relevant for epidemiological investigations around clus-
tered cases of TB [11]. Briefly, the genomic bacterial
DNA was prepared by the cetyltrimethylammonium
bromide (CTAB) method [12] from cultured strains.
Spoligotyping using primers designated DRa and DRb
(with DRa biotinylated at 5’) to amplify the whole Direct
Repeat (DR) region was performed as described previ-
ously [6]. As spoligotyping used alone may overestimate
the number of potentially linked isolates, it was used in
association with VNTR typing using exact tandem re-
peats ETR-A to ETR-E as a 2nd-line VNTR typing
method as reported [7].
After the completion of the study, a subset of 44M.
tuberculosis isolates found to be clustered by combin-
ation of spoligotyping and 5-loci VNTRs was retrospect-
ively typed by using the 12-loci MIRU-VNTRs system
described later [13]; since it allows a better discrimin-
ation than the 5-loci VNTRs that were available when
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the prospective study was planned back in 1998. The
PCR-based 12-loci MIRU-VNTR typing was performed
using primers described previously [13,14], and the pres-
ence and size of each PCR product was determined
manually by electrophoresis on an agarose gel, followed
by staining with ethidium bromide as reported previ-
ously [15]. Note that although theoretically ETR-D and
E correspond to MIRU locus 4 and 31, the primers and
calculations based on ETR determination according to
the protocols of Frothingham and Meeker-O’Connell [7]
versus Supply et al. [13,14], might not turn up in identi-
cal copy number for ETR-D and MIRU-4.
Genotype analysis, database comparison, and recent
transmission rate
Spoligotype patterns as octal codes, 5-loci VNTRs, and
12-loci MIRU-VNTR data were entered in the SITVIT2
proprietary database of the Institut Pasteur de la
Guadeloupe, which is an updated in-house version of
the publicly released SpolDB4 [16] and SITVITWEB
[17] databases. In this database, Spoligotype Inter-
national Type (SIT), VNTR International Type (VIT),
and MIRU International Type (MIT) designate identical
patterns shared by 2 or more patient isolates, whereas
“orphan” designates patterns reported for a single isolate
that does not correspond to any of the patterns recorded
in the repository of the SITVIT2 database. Major phylo-
genetic clades were assigned according to signatures ini-
tially provided in SpolDB4, and slightly revised in
SITVITWEB by the addition of 5 “new rules” for defin-
ition of variants within 62 existing lineages/sub-lineages.
These include specific signatures for various M. tubercu-
losis complex members, as well as rules defining major
lineages/sub-lineages for M. tuberculosis stricto sensu,
i.e., the Beijing clade, the Central Asian (CAS) clade and
two sublineages, the East African-Indian (EAI) clade and
nine sublineages, the Haarlem (H) clade and three
sublineages, the Latin American-Mediterranean (LAM)
clade and 12 sublineages, the “Manu” family and three
sublineages, the S clade, the IS6110–low-banding X
clade and four sublineages, and an ill-defined T clade
with five sublineages. Lastly, the recent transmission rate
was estimated by the N-1 method [5], according to for-
mula T(c) - N(c)/T(a), where T(c) is the total number of
clustered isolates, N(c) is the number of clusters, and T
(a) is the total number of isolates.
Epidemiological, phylogenetical, and statistical analysis
Epidemiological and demographic data collected were
analyzed using Epi-Info 3.2.2 software (Centers for Dis-
ease Control and Prevention, Atlanta, GA; free down-
load available at http://www.cdc.gov/epiinfo). The
statistical analysis was carried out with STATA® 9.0 soft-
ware (StataCorp, College Station, TX). Patients were
divided into 2 groups: clustered patients (infected by
strains harboring identical genotypic patterns), versus
unclustered patients. The Chi-2, Fischer exact, and Stu-
dent tests (according to the variables considered) were
carried out using univariate analysis in order to test risk
factors in function with clustering of the isolates. Odds
ratio were calculated with a confidence interval of 95%.
A qualitative analysis of the data collected was
performed to evaluate the possible ways of infection.
The phylogenetical analysis of genotyping data was car-
ried out using “PAUP 4.0” software (available at: http://
paup.csit.fsu.edu) and UPGMA (Unweighted Pair Group
Method with Arithmetic Averages) algorithm on com-
bined genotyping data.
Results
Demographic characteristics, geographic localization, and
drug resistance
Epidemiological and demographic data of the 129 pa-
tients with a culture-positive, confirmed M. tuberculosis
infection are summarized in Table 1. The population of
TB patients in Guadeloupe is characterized by a male to
female sex-ratio of 1.5 with a median age of patients of
40 years. Overall TB principally affected men in the age
group 40–59 years (n = 32/77 or 41.6% of all male pa-
tients); male patients being older than females (median
age of 42 vs. 36 years). More than 1 out of 2 patients
was foreign-born (63/129 or 48.8% French vs. 66/129 or
51.2% foreign-born), who had been residing in
Guadeloupe for approximately 10 years at the time of
diagnostic. The exact place of birth was available for
126/129 patients: 53/126 (42.1%) were born in Haiti, 5/
126 (4%) in Dominican Republic and 52/126 (41.3%) in
French overseas departments (Guadeloupe n = 43,
Martinique n = 1, French Guiana n = 1), or other depart-
ments in continental France (n = 7). Foreign-born pa-
tients were significantly younger (median age 36 years
vs. 50 years for French patients; p < 0.001); the propor-
tion of patients below 60 years being 63/66 or 95.5%
among foreign-born vs. 40/63 or 63.5% for French pa-
tients (p < 0.001). Lastly, men were older than females
among the foreign-born group: 39 vs. 34 years as com-
pared to 49 vs. 58 years for French nationals (difference
not significant statistically). These results corroborate
published data from mainland France for French vs.
foreign-born patients for the year 2004 [18]. Geographic
localization of patients showed that 27/34 cities of
Guadeloupe archipelago (including its island dependen-
cies of Saint-Martin, Saint-Barthelemy, Marie-Galante,
Desirade, and Les Saintes) declared at least one case of
tuberculosis during the period of the study; 6 areas
shared 69/116 (59.5%) of the TB cases for which this in-
formation was available: Saint-Martin 20/116 (17.2%);
Les Abymes 20/116 (17.2%); Le Gosier, 10/116 (8.6%);
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Table 1 Demographical and epidemiological data of the 129 tuberculosis patients from Guadeloupe in function of
their place of birth
Parameters studied Total number
(%) (n = 129)
Foreign-born patients number
(%) (n = 66)
French patients number
(%) (n = 63)
p
Sex
male 77 (59.7) 35 (53.0) 42 (66.7) NS
female 52 (40.3) 31 (47.0) 21 (33.3)
unknown 0 0 0
Age group
0-14 years 1 (0.8) 1 (1.5) 0 (0) <0.001
15-24 years 12 (9.3) 10 (15.2) 2 (3.2)
25-39 years 44 (34.1) 26 (39.4) 18 (28.6)
40-59 years 46 (35.7) 26 (39.4) 20 (31.7)
>60 years 26 (20.2) 3 (4.5) 23 (36.5)
unknown 0 0 0
Employment a
no 65 (70.7) 37 (72.5) 28 (68.3) NS
yes 27 (29.3) 14 (27.5) 13 (31.7)
unknown 37 15 22
Positive HIV status
no 77 (75.7) 34 (61.8) 43 (91.5) <0.001
yes 25 (24.5) 21 (38.2) 4 (8.5)
unknown 27 11 16
Smoker
no 76 (80.0) 45 (83.3) 31 (75.6) NS
yes 19 (20.0) 9 (16.7) 10 (24.4)
unknown 34 12 22
Excessive alcohol user b
no 69 (71.9) 47 (85.5) 22 (53.7) <0.001
yes 27 (28.1) 8 (14.5) 19 (46.3)
unknown 33 11 22
Drug user
no 81 (87.1) 50 (96.2) 31 (75.6) <0.01
yes 12 (12.9) 2 (3.8) 10 (24.4)
unknown 36 14 22
Prior history of active TB
no 90 (87.4) 53 (93.0) 37 (80.4) NS
yes 13 (12.6) 4 (7.0) 9 (19.6)
unknown 26 9 17
Sputum AFB smear result
no 38 (29.5) 21 (31.8) 17 (27.0) NS
yes 91 (70.5) 45 (68.2) 46 (73.0)
unknown 0 0 0
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Pointe-à-Pitre, 8/116 (7.0%); Baillif, 6/116 (5.2%); and
Basse-Terre, 5/116 (4.3%). Regarding drug resistance,
10/129 (7.8%) cases were associated to any drug resist-
ance; cumulative resistance to isoniazid and rifampicin
(multidrug resistance or MDR) concerned 3/129 (2.3%)
cases.
Access to healthcare and delay to diagnosis
Access to healthcare was defined as the delay comprised
between the first symptoms of TB and the date of its
clinical suspicion. This interval includes 2 periods: the
access time to 1st medical contact which is the delay
comprised between the 1st symptoms of TB and the date
of 1st medical contact for those symptoms, and the time
of clinical suspicion defined as the delay extending from
the date of 1st medical contact to the date of clinical sus-
picion of TB. In the present study, the median access
time to 1st medical contact and to clinical suspicion were
equal to 16 and 26.5 days respectively leading to a me-
dian delay to healthcare of 74.5 days. We observed that
patients treated after clinical suspicion presented a sig-
nificantly longer median delay of access to healthcare
than those treated after bacteriological investigations
(median delay of 80 vs. 37 days respectively; p < 0.017);
due to a longer access time to 1st medical contact (me-
dian delay of 19 vs. 8 days respectively) and a signifi-
cantly longer delay of clinical suspicion (33.5 vs.
10.5 days respectively; p < 0.03). Remarkably, in both
groups of patients, the diagnostic delay was longer than
the access time to the first medical contact. The primary
reason for consulting a physician for a first medical
contact was persistent cough with fever (median 16 days).
TB was suspected at the 1st medical contact for 69/107
(64.5%) patients, 2nd contact for 22/107 (20.6%), pa-
tients, 3rd contact for 10/107 (9.3%) patients, and later
for 6/107 (5.6%) patients. Patients for whom a presump-
tive diagnosis of TB was made at the 1st medical contact
had a longer delay in consulting the physician after the
onset of clinical symptoms (30.5 vs. 3.5 days for other
patients; p < 0.0001). Nonetheless, these were diagnosed
for TB significantly faster than the remaining patients
(10.5 vs. 74 days; p = 0.025) most probably due to a more
advanced state of the disease; which suggests that efforts
targeting early medical diagnosis of TB must be
intensified.
Socioeconomic characteristics
As summarized in Table 1, only 27/92 (29.3%) patients had
a regular work (employees n = 13, workmen n = 4, farmers
n = 4, craftsmen n = 3, management n = 2, and unspecified
job n = 1). The remaining 65/92 (70.7%) patients were job-
less, nonetheless 19/65 (29.2%) reported doing small un-
declared jobs from time to time. Overall, the TB patients
constituted a low income group with an average earning of
824 EUR/month (range, 40 – 5000 EUR). The underprivil-
eged nature of the TB patient group was also reflected by
the fact that 18.9% shared a single room with 2 or more per-
sons, and 52.2% used regularly public transport. Regarding
addiction, 27/96 (28.1%) were regular alcohol consumers
(more than 4 glasses of alcoholic beverages/day), and 19/95
(20.0%) were smokers among whom 10/19 (52.6%) smoked
more than a packet of 20 cigarettes/day. Drug consumption
Table 1 Demographical and epidemiological data of the 129 tuberculosis patients from Guadeloupe in function of
their place of birth (Continued)
Drug resistance
no 119 (92.2) 61 (92.4) 58 (92.1) NS
yes 10 (7.8) 5 (7.6) 5 (7.9)
unknown 0 0 0
Localization of TB c
pulmonary 114 (88.4) 54 (81.8) 60 (95.2) <0.02
extrapulmonary 15 (11.6) 12 (18.2) 3 (4.8)
unknown 0 0 0
Treatment outcome d
completed treatment / cured 63 (55.8) 37 (66.1) 26 (45.6) NS
died before treatment completed 17 (15.0) 6 (10.7) 11 (19.3)
lost to follow up 33 (29.2) 13 (23.2) 20 (35.1)
unknown 16 10 6
a Employment: the “yes” includes patients who answered positively to the question “Do you currently have a regular professional activity?”
b Excessive alcohol user: “yes” concerns patients drinking more than 4 glasses of alcoholic beverages per day.
c Localization of TB: Pulmonary, patients without any extrapulmonary manifestation of TB; Extrapulmonary, patients with extrapulmonary or disseminated TB, as
well as with combined manifestations of extrapulmonary and pulmonary TB.
d Treatment outcome: “completed treatment” includes only cured patients.
Abbreviations: NA Not Applicable, NS Non Significant (significance level below 0.05).
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was known for 93 patients, and 12/93 (12.9%) declared con-
suming cannabis and/or crack regularly. Lastly, only 10/91
(11%) patients affirmed having frequent relation to public,
although 53/91 patients (58.2%) attended church regularly.
During the 2 years preceding the diagnosis of TB, 17/89
(19.1%) patients had carried out 21 trips in 14 French de-
partments (11 French and 6 foreign-born). In general, the
French nationals mostly traveled to mainland France (10/
11), as opposed to foreign-born patients who traveled within
the French departments of Americas (4/6). Despite the
highly precarious living conditions of the patient group, 27/
89 (30.3%) patients also carried out 42 international travels
in 12 countries (mostly to neighboring Caribbean countries).
These trips outside the French overseas departments essen-
tially concerned foreign-born patients returning to their
homeland, the highest proportion being made up of Haitians
(n = 16).
Clinical characteristics and treatment outcome
Table 1 also describes clinical characteristics of the 129
patients of the study. Data collected showed that
extrapulmonary TB was more frequent among the foreign-
born group of patients as compared to French nationals
(12/66 or 18.2% vs. 3/63 or 4.8%; p <0.02). Previous history
of TB was known for 103/129 patients; 90 were new cases
(87.4%) while 13 patients (14.4%) were previously treated for
TB (8 pulmonary, 1 extrapulmonary, 1 pulmonary case asso-
ciated with a genital form, 3 unknown). Underlying medical
conditions were known for 92/129 patients, and revealed
that 38.0% (35/92) of the patients were also simultaneously
treated for associated diseases (diabetes, prostate cancer,
liver cancer, arterial hypertension, asthma). HIV serology
was known for 102/129 patients (55 foreign-born and 47
French nationals) with a global TB/HIV co-infection rate of
24.5% (25/102); the latter was significantly higher among
foreign-born group (21/55 or 38.2% vs. 4/47 or 8.5% for
French nationals; p = 0.001). This co-infection rate of 24.5%
places Guadeloupe largely ahead of metropolitan France
with 10% of TB/HIV co-infection for the same time period
[19].
Treatment outcome was known for 113/129 patients;
63/113 (55.8%) were cured, 33/113 (29.2%) were lost to
follow-up, and 17/113 (15%) died within 4 months after
the diagnostic of TB, mostly due to underlying health
conditions (Table 1). Among those lost of sight (n = 33),
26 patients followed their initial treatment for an un-
specified period of time (median delay of 4 months after
the initial phase of treatment in hospital, no information
available for 7 patients).
Genotyping, clustering, and phylogenetical analysis
Spoligotyping of the 129 clinical isolates generated 57
different patterns presented in Figure 1 and Additional
file 1: Table S1, among which 49 profiles were already
present in our database with a SIT number, 3 profiles
matched orphan patterns in the database creating new
shared-types (SITs 1913, 2383, and 2689), and 5 were
not reported earlier and labeled as orphan. A total of 90/
129 (69.8%) isolates were grouped into 18 clusters (2 to
12 strains per cluster) while 39/129 (30.2%) were unique
in this study. The overall lineage distribution was as fol-
lows: LAM (n = 38/129 or 29.5%), ill-defined T family
(n = 39/129 or 30.2%), Haarlem (n = 30/129 or 23.3%), X
clade (n = 8/129 or 6.2%), S family (n = 3/129 or 2.3%),
EAI (n = 2/129 or 1.6%), and AFRI (n = 1/129 or 0.8%).
We also looked in the updated version of the SITVIT2
database for the geographical distribution of all clustered
isolates found in Guadeloupe vs. their relative distribu-
tion in all the 3 French Departments of the Americas
(Guadeloupe, Martinique, and French Guiana), Caribbean,
South and central America, as well as the remaining coun-
tries worldwide (database interrogation made on April
25th 2013; Table 2). One can observe essentially 5
kinds of situations: (i) ubiquitous spoligotypes present
in a very high proportion in the database (SIT42/LAM9,
SIT50/H3, SIT53/T1), (ii) patterns that are shared be-
tween the 3 French departments, Caribbean, South and
Central America and the rest of the world, although in
varying proportions (SIT2/H2, SIT3/H3, SIT7/T1, SIT20/
LAM1, SIT44/T5, SIT45/H1, SIT51/T1, SIT93/LAM5,
SIT122/T1), (iii) patterns with a phylogeographical spe-
cificity for South and Central America that are present
in Caribbean including Guadeloupe (SIT17/LAM2);
(iv) patterns that are shared between Caribbean and the
rest of the world but absent in South and Central America
(SIT5/T1, SIT70/X3); (v) patterns that show phylogeo-
graphical specificity for French Departments in general
and Guadeloupe in particular (SIT14/X3, SIT103/H1,
SIT1087/T1).
Genotyping of the 5-loci VNTRs provided complete
and/or interpretable results for 116/129 strains (Figure 1)
with 15 clusters (n = 106 isolates, 2–27 strains/cluster).
Note that 9 of the 10 unclustered strains (with the ex-
ception of pattern 96245) matched an existing VIT num-
ber in the database, and no VIT numbers were newly
created due to a newly found pattern or a match with
preexisting orphan in the database.
The combination of spoligotypes and VNTRs revealed
76 distinct profiles for the 129 isolates: 58 corresponded
to unique vs. 18 for clustered strains (n = 71, 2–9 iso-
lates/cluster; labeled as A, B1, B2, C1, C2, C3, D, E, F,
G1, G2, G3, G4, H, I1, I2, I3, and J in Figure 1). When
epidemiological data were analyzed in combination with
clustering, we observed that mean age of patients among
the 18 clusters varied from 27 (cluster I1, n = 2) to
59 years old (cluster G2, n = 3), and that the male to fe-
male sex ratio varied from 0 (cluster E, n = 2) to 3 (clus-
ter A, n = 4); with 4 clusters composed exclusively of
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Figure 1 (See legend on next page.)
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male patients (clusters C1 n = 3; D n = 3; G2 n = 3; J n =
2). Regarding drug resistance, 3 clusters contained 1
MDR strain each (clusters J, C2, and B2; the MDR strain
of C2 was simultaneously resistant to INH, RIF, EMB
while that of cluster J to INH, RIF, EMB, SM). Further-
more, 1 cluster contained 2 monoresistant strains (to
SM and INH, cluster G4); while 2 others contained 1
monoresistant strain each to INH (cluster C3) and to
SM (cluster H).
It should be underlined that the cluster I1 composed
of the youngest patients, did not contain any drug resist-
ant strains, and that the 3 patients infected with MDR
strains were simultaneously HIV-positive. A comparison
with the SITVIT2 database showed that the combined
spoligotyping + 5-loci VNTR profiles of the 6 clusters in-
cluding resistant strains, matched mainly strains from
Haiti. For example, 9/10 strains in the database sharing
cluster J pattern (SIT5/VIT193) were isolated from Hai-
tian patients. Similarly, 14/16 patients with cluster B2
pattern (SIT93/VIT3); 20/24 strains with cluster C2 pat-
tern (SIT17/VIT10), 26/36 strains with cluster C3 pat-
tern (SIT20/VIT10), and 34/84 of strains with cluster G4
pattern (SIT50/VIT18), were also isolated from Haitian
patients in the database. Unfortunately, drug resistance
profiles were not systematically available in the database,
making it impossible to definitely link the genotypes and
drug resistance of isolates actively circulating between
Haiti and Guadeloupe.
Retrospective evaluation of clustered isolates by 12-loci
MIRU typing
Because during the time course of this 7 years prospect-
ive study, the TB molecular typing methodology evolved
with the introduction of 12-loci MIRU typing [13,14],
we decided to retrospectively genotype a subset of 44M.
tuberculosis strains clustered by the combination of
spoligotyping and 5-loci VNTRs. The results obtained
(Table 3) showed that 26/44 (59.1%) strains remained
clustered vs. 18/44 (40.9%) being unique by the combin-
ation of the 3 methods. This allowed decreasing the
clustering rate and recent transmission rates in this sub-
set from 55% and 41.1% respectively, to 25.5% and 16.7%
respectively.
Contact tracing investigations and risk factor analysis
Rebuilding the ways of infection of TB cases due to a re-
cent infection was carried out by cross analyzing
genotyping data in conjunction with results of contact
tracing investigations, as well as data collected through
individual interviews. Contact tracing alone suggested a
potential common source of infection for 6 patients of
the study, which in our opinion is underestimated since
only 54% of the TB cases diagnosed could be effectively
covered by investigations among patient’s entourage.
Genotyping results combined with epidemiologic inves-
tigations underlined 23 TB cases categorized as recent
transmission. Finally, the consideration of all the 3 pa-
rameters confirmed active transmission of TB for 24/129
(18.6%) of cases.
A Univariate analysis of risk factors was performed in
function to the clustering of M. tuberculosis isolates and
available demographic, epidemiologic, clinical, and so-
cioeconomic data. However, the results summarized in
Table 4 showed that none of the risk factors tested could
be significantly associated with active transmission of
TB. Only the factor “age of patients below 60 years” was
close to the statistical limit of significance (p = 0.06).
Discussion
This study is the first prospective epidemiological and
molecular study of TB transmission in the French
overseas department of Guadeloupe. When compared to
TB epidemiology in mainland France, the most striking
difference was the significantly higher proportion of TB/
HIV co-infected patients in Guadeloupe (24.5% vs. 10%
respectively; [19]). However, an almost similar propor-
tion of drug-resistance and TB incidence were observed
in 2005: the proportion of drug resistant isolates being
7.8% vs. 8.8%, respectively, in Guadeloupe and continen-
tal France [19], and an incidence of 8.1 vs. 8.9 cases per
100,000 inhabitants [20]. Similarly to mainland France,
men represented around 60% of TB patients in
Guadeloupe a trend accentuated for the age group 40–
60 years in mainland France (68% of TB patients) and
40–59 years in Guadeloupe (71.1% of TB patients [20]).
Lastly, TB in Guadeloupe was characterized by immigra-
tion with 51.2% of foreign-born patients in our study,
which is slightly higher than 48% in mainland France in
2005, but significantly lower than the 69% of foreign
born patients observed in French Guyana (185/268;
p < 0.001; [20,21]). Immigrants in Guadeloupe mainly
originated high TB incidence and AIDS burden sur-
rounding Caribbean islands of Haiti and Dominican Re-
public, with reported TB incidence in 2005 of 305 and
(See figure on previous page.)
Figure 1 UPGMA dendrogram obtained through a combined numerical analysis of spoligotypes and VNTR profiles of the 129M.
tuberculosis clinical isolates from Guadeloupe. The letters in front of the tree correspond to the following information: A: SIT numbers of the
spoligotype profiles with, in brackets, the strain numbers; B: binary spoligotypes; C: 5-loci VNTR profiles. The “x” symbol among a profile indicates
a missing or uninterpretable result; D: clusters numbers; E: clades attribution of the spoligotype profiles.
Ferdinand et al. BMC Infectious Diseases 2013, 13:364 Page 8 of 14
http://www.biomedcentral.com/1471-2334/13/364
Table 2 Worldwide geographical distribution of major SITs found in Guadeloupe according to the SITVIT2 database (interrogation made on April 25th, 2013)






GLP MTQ GUF Caribbean South and Central America Othercountries
2 □□□□□□□□□□□□□□□□□□□□□□□□■□□□□□□■□□□□■■■■■■■ H2 393 18 5 24 21(CUB), 37(HTI) 35(ARG), 21(BRA), 2(COL), 3(HND), 2(PAN), 1
(PRY)
224
3 □□□□□□□□□□□□□□□□□□□□□□□□■■■■■■□■□□□□■■■■■■■ H3 105 4 0 0 3(CUB), 1(HTI) 2(ARG), 7(BRA), 3(COL), 1(SUR), 1(VEN) 83
5 □□□□□□□□□■■□■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ T1 30 3 2 4 7(HTI) 0 14
7 □■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ T1 77 4 0 4 1(BHS), 2(HTI) 1(PER), 2(PRY) 63
14 ■□■□□□□□□□□□■■■■■□■■■■■■■■■■■■■■□□□□■■■■■■■ X3 42 27 6 2 0 1(VEN) 6
17 ■■□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ LAM2 656 22 4 12 1(CUB), 9(DOM), 22(HTI),
1(TTO)
2(ARG), 184(BRA), 13(COL), 1(PAN), 1(PER), 1
(PRY), 179(VEN)
204
20 ■■□■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ LAM1 811 8 1 20 5(CUB), 26(HTI), 3(JAM) 2(ARG), 147(BRA), 14(COL), 5(PER), 1(PRY), 42
(VEN)
537
42 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ LAM9 3282 24 8 31 Ubiquitous Ubiquitous Ubiquitous
44 ■■■■■■■■■■■■■■■■■■■■■■□■■■■■■■■■□□□□■■■■■■■ T5 210 4 0 6 0 3(ARG), 3(BRA), 1(SUR), 4(VEN) 189
45 ■■■■■■■■■■■■■■■■■■■■■■■□■□□□□□□■□□□□■■■■■■■ H1 106 8 14 0 1(HTI), 3(LCA) 9(BRA), 8(COL), 1(PAN) 62
50 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■ H3 3330 23 16 88 Ubiquitous Ubiquitous Ubiquitous
51 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□□□□ T1 279 12 0 13 17(HTI), 3(JAM) 4(ARG), 40(BRA), 1(PER), 10(VEN) 179
53 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ T1 6104 39 25 84 Ubiquitous Ubiquitous Ubiquitous
70 ■■■□□□□□□□□□■■■■■□■■■■■■■■■■■■■■□□□□■■□■■■■ X3 116 3 0 6 8(BHS), 8(HTI), 1(TTO) 0 90
93 ■■■■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ LAM5 359 19 0 9 7(DOM), 15(HTI), 1(TTO) 2(ARG), 43(BRA), 2(COL), 17(PER), 6(PRY), 94
(VEN)
144
103 ■■■■■■■■■■■■■■■■■■■■■■□■■□□□□□□■□□□□■■■□■■■ H1 3 3 0 0 0 0 0
122 ■■■■■■■■■■■■■■■■■■■■■■■■■□■■■■■■□□□□■■■■■■■ T1 27 2 0 0 0 1(COL), 1(PAN) 24
1087 □□■■■■■■■■■■■■■■■■■■□□□□□■■■■■■■□□□□■■■■■■■ T1 4 2 0 0 1(HTI) 0 1
a Distribution in the 3 French Departments of Americas, the Caribbean islands, South and Central America, and elsewhere in the world according to the SITIVT2 database. The 3-letters code for Argentina (ARG), Brazil
(BRA), Bahamas (BHS), Columbia (COL), Cuba (CUB), Dominican Republic (DOM), French Guiana (GUF), Guadeloupe (GLP), Haiti (HTI), Honduras (HND), Jamaica (JAM), Martinique (MTQ), Panama (PAN), Paraguay (PRY),



















91 cases/100 000 inhabitants [22], which might explain
the relatively high rate of TB/HIV coinfected patients
among foreign born patients in our study (38.2% vs.
8.5% for French patients; p = 0.001).
The present study was meant to specifically evaluate
the use of genotyping to quantify recent TB transmission
with a focus on risk factors and access to health care
during 1999–2005; and was followed by a study on evo-
lution of TB cases during 2006–2011 [23]. We therefore
attempted to compare TB evolution during these 2 time
periods. As summarized in Table 5, one may notice a
statistically significant decrease during the period 2006–
2011 for 4 out of 9 parameters compared, namely, the
proportion of foreign-born patients; patients lost of site;
excessive alcohol users; drug addicts. The decrease in
the proportion of foreign-born patients from 51.2% vs.
38.3% may be linked to the decrease in the proportion of
migrants observed in Guadeloupe from 6.5% to 4.7% in
2010 [24,25]. It may be noted that the decrease among
lost of site is statistically significant both among foreign-
born and French patients, while the decrease in exces-
sive alcohol users and drug addicts was limited to
French patients only. Regarding the 5 parameters that
did not change significantly (Table 5), it might be worth-
while to comment on trends for TB/HIV coinfection
which remained stable between the periods 1999–2005
and 2006–2011 (24.5% to 26.6%), despite a slight but
non-significant increase among both French-born (8.5%
to 13.9%) and foreign born patients (38.2% vs. 46.9%).
However, considering the reported decrease in the inci-
dence of HIV/AIDS infection in Guadeloupe from 20 to
11.7 cases/100 000 inhabitant between 2003 and 2009
[26,27], this observation might be explained on the basis
of continued influx of a varying proportion of migrant
workers from poor surrounding countries such as Haiti
and Dominican Republic, where both TB and HIV/AIDS
Table 3 Retrospective 12-loci MIRU analysis of a subset of 44M. tuberculosis strains initially clustered by using the
combination of spoligotyping with 5-loci VNTRs
Cluster SIT Spoligotype VNTR VIT 12-loci MIRU MIT Nb of strains
F (n = 2) 3 □□□□□□□□□□□□□□□□□□□□□□□□■■■■■■□■□□□□■■■■■■■ 32332 17
224313153223 181 1
225313153223 810 1
J (n = 2) 5 □□□□□□□□□■■□■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 42533 193 223325153322 15 2




C2 (n = 5) 17 ■■□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 22433 10
224226163321 26 4
Not Amplified 1
C3 (n = 3) 20 ■■□■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 22433 10
223226163321 307 2
223226193321 1048 1
A (n = 4) 42 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 21233 2
224226143321 738 1
224226153321 25 3
B1 (n = 4) 42 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 21433 3
224226153321 25 3
233126142321 1539 1
I1 (n = 2) 44 ■■■■■■■■■■■■■■■■■■■■■■□■■■■■■■■■□□□□■■■■■■■ 32433 23 223326153323 236 2













B2 (n = 7) 93 ■■■■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 21433 3
224226143321 738 2
224226153321 25 5
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remain highly endemic [1]. This assumption is corrobo-
rated by the fact that the proportion of extrapulmonary
TB increased in Guadeloupe from 11.6% in 1999–2005
to 15.6% in 2006–2011 (Table 5). In our study, foreign-
born patients were more likely to be TB/HIV co-infected
and also showed a higher proportion of extra pulmonary
disease. These observations are likely not independent,
although stratified analysis was not performed to be
conclusive.
Regarding geographical mapping of TB cases, 5 out of
6 cities sharing 60% of TB burden in our study were
characterized by higher population densities than the
mean reported for Guadeloupe, and 3 out of 6 were also
characterized by a higher proportion of underprivileged
populations (more than 12.6% [28,29]). Furthermore, TB
patients in our study were characterized by a very high
rate of unemployment (70.7%; Table 1) and a below
average income close to the official limit of poverty in
France (monthly income of 824 EUR vs. 812 EUR/month
in 2001; [29,30]).
Our results also provided with a first insight into the man-
agement of TB in Guadeloupe, and revealed that 38/107
(35.5%) of patients for which information was available,
consulted more than one physician before being diagnosed
for TB. Interestingly, the management of patients improved
in the period 2006–2011 [23] with a median delay of 55 days
Table 4 Univariate analysis of risk factors in relation to the prospective genotype based clustering analysis of 129
M. tuberculosis isolates following spoligotyping and 5-loci VNTRs (clustered, n = 71 vs. unclustered, n = 58)




Male sex 40 (56.3) 37 (63.8) 0.73 [0.34-1.58] 0.40
Low incomes (< 465 €) 21 (29.6) 14 (24.1) 2.03 [0.73-5.68] 0.13
Alcohol abuse a 15 (21.1) 12 (20.7) 0.73 [0.25-2.15] 0.50
Pulmonary localization of TB 64 (90.1) 50 (86.2) 1.46 [0.44-4.87] 0.50
Age < 60 years 61 (85.9) 42 (72.4) 2.32 [0.89-6.16] 0.06
HIV positive 16 (22.5) 9 (15.5) 1.41 [0.51-3.96] 0.50
Foreign born 36 (50.7) 30 (51.7) 0.96 [0.48-1.92] 0.90
Underlying conditions b 30 (42.3) 28 (48.3) 0.78 [0.37-1.67] 0.50
Previous medical problems c 16 (22.5) 19 (32.8) 0.78 [0.25-2.41] 0.60
Diagnosis delay d > 26.5 j 44 (62.0) 43 (74.1) 0.57 [0.25-1.29] 0.14
Hospitalization 18 (25.4) 10 (17.2) 1.80 [0.64-5.13] 0.20
a patients drinking more than 4 glasses of alcoholic beverages per day.
b homeless or living in shelters.
c other than preliminary tuberculosis.
d median delay between the first medical contact for tuberculosis symptoms and clinical suspicion of tuberculosis.
Table 5 Evolution of epidemiological and clinical data concerning locally born and foreign born populations of TB
patients in Guadeloupe between 1999–2005 (this study) and 2006–2011 (Cadelis et al., 2012 [23])














Foreign born 66 (51.2) 49 (38.3) <0.05 NA NA
Male 77 (59.7) 80 (62.5) NS 31 (47.0) 24 (49.0) NS 42 (66.7) 56 (70.9) NS
Prior history of active TB 13 (12.6) (a) 25 (19.5) NS 4 (7.0) (g) 8 (16.3) NS 9 (19.6) (l) 17 (21.5) NS
Extrapulmonary TB 15 (11.7) 20 (15.6) NS 12 (18.2) 12 (24.5) NS 3 (4.8) 8 (10.1) NS
HIV+ 25 (24.5) (b) 34 (26.6) NS 21 (38.2) (h) 23 (46.9) NS 4 (8.5) (m) 11 (13.9) NS
Lost of sight 33 (29.2) (c) 8 (6.3) <0.001 13 (23.2) (i) 1 (2.0) <0.01 20 (35.1) (n) 7 (8.9) <0.001
Excessive alcohol user 27 (28.1) (d) 22 (17.2) 0.05 8 (14.5) (h) 3 (6.1) NS 19 (46.3) (o) 19 (24.1) <0.025
Smoker 19 (20) (e) 30 (23.4) NS 9 (16.7) (j) 7 (14.3) NS 10 (24.4) (o) 23 (29.1) NS
Drug user 12 (12.9) (f) 6 (4.7) <0.05 2 (3.9) (k) 1 (2.0) NS 10 (24.4) (o) 5 (6.3) <0.01
– Abbreviations: NA Not applicable.
– For Total population of patients: Information available for (a) 103/129 cases, (b) 102/129 cases, (c) 113/129 cases, (d) 96/129 cases,.
(e) 95/129 cases, (f) 93/129 cases.
– For foreign-born patients: information available for (g) 57/66 cases, (h) 55/66 cases, (i) 56/66 cases, (j) 54/66 cases, (k) 52/66 cases.
– For French-born patients: information available for (l) 46/63 cases, (m) 47/63 cases, (n) 57/63 cases, (o) 41/63 cases.
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between the 1st symptoms and clinical suspicion of TB in-
stead of 74.5 days in 1999–2005; as well as the delay for clin-
ical suspicion of TB after a 1st medical consultation (18 days
vs. 26.5 days). Comparison of foreign-born vs. French pa-
tients did not reveal significant differences in access to
healthcare. Regarding treatment outcome, only 55.8% of pa-
tients were cured in our study since 15.0% of them de-
ceased, and 29.2% were lost to follow up. These relatively
mediocre TB management indicators as compared to
Europe (74% treatment success rate, 7% deceased, 12% lost
to follow up; [31]), may indirectly be linked to the lack of
awareness among the patient population in Guadeloupe,
which is characterized by poor living conditions underlined
earlier.
As far as feasibility of molecular typing in a prospective
study is concerned, our results demonstrated that PCR-
based spoligotyping not only correctly identified potential
“outbreak” strains, but also allowed a fine characterization of
the phylogeographical specificity of certain clones, e.g.,
SIT14/X3, SIT103/H1, and SIT1087/T1 (Table 2). The 2nd-
line genotyping using 5-loci VNTRs allowed reducing the
overestimation of clustering by spoligotyping [32]. However,
it was apparently not enough discriminatory since 12-loci
MIRUs performed retrospectively allowed to reduce both
the clustering and recent transmission rates (Table 3). This
observation argues for the use of spoligotyping with ex-
tended MIRU typing formats. In our study, mixed clusters
involving both foreign-born and French patients concerned
11/18 or 61% of clusters by spoligotyping and 5-loci VNTRs;
however after retrospective 12-loci MIRU typing their num-
ber was reduced to 5 mixed clusters containing a total of 18
cases. Thus the suggested minimal requirement based on
our study is 12-loci MIRUs, although the optimal format for
molecular epidemiological investigations today is a new 15-
loci format [33,34]. Nonetheless, seeing the very low recent
transmission rates found in our study, the future investiga-
tions should be extended to the sister island of Martinique,
as well as French Guiana – since important migratory flows
and exchanges exist between Guadeloupe and the 2 other
French departments of the Americas. This might help detect
both migratory flows, as well as direct and casual contacts,
leading to the ongoing TB epidemic.
Last but not least, thanks to the comparison with an
updated SITVIT2 database, we were able to conclude on
the phylogeographical specificity of the circulating M. tuber-
culosis clones in Guadeloupe and surrounding regions. Most
of this data commented earlier in the text clearly shows the
predominance of evolutionary recent Euro-American group
of isolates [16,17] in our study. However, LAM, Haarlem
and T lineages predominated in Guadeloupe, while the X
lineage strains of suspected Anglo-Saxon descent [16,17,35]
were present to a smaller extent. Thus the bulk of TB trans-
mission in Guadeloupe may be attributed to TB lineages
shared with neighboring areas in the Caribbean and South
and Central America [21,36]. Nonetheless, we further identi-
fied some clones such as SIT14/X3, SIT103/H1, and
SIT1087/T1 (Table 2), which are highly specific for
Guadeloupe. We now hope to extend a detailed molecular
epidemiological study on the M. tuberculosis isolates from
the 3 French departments isolated in 2006–2012 so as to
see the evolution of above mentioned genotypes in time and
space. Ultimate comparison of clusters retained after 12-
and 15-loci MIRUs should be done using 24-loci MIRU-
VNTRs [34] followed by the whole genome sequencing [37]
of specific clones, in order to shed light on epidemiological
and phylogenetical links between strains involved in active
transmission, as well as to quantify how much M. tubercu-
losis isolates vary at the genomic level between epidemiolog-
ically linked patient clusters [38].
Conclusions
The present prospective genotyping study aimed to investi-
gate TB transmission during a 7 year period in Guadeloupe,
as well as to study the access to health care and follow-up
of the TB patients diagnosed. The results obtained under-
line that the ongoing TB transmission in this insular, low
TB-incidence setting of Guadeloupe was characterized by:
(i) a significant proportion of imported cases of the disease
from neighboring islands; (ii) a significantly higher TB/
HIV coinfection among foreign-born cases; and, (iii) a
higher proportion of cases affecting older age-group among
French patients due to reactivation. Last but not least, this
study also emphasized the need for universal typing using
spoligotyping and 15-loci MIRUs in future prospective
studies in Guadeloupe.
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